Literature DB >> 27084944

MBROLE 2.0-functional enrichment of chemical compounds.

Javier López-Ibáñez1, Florencio Pazos1, Mónica Chagoyen2.   

Abstract

Metabolites Biological Role (MBROLE) is a server that performs functional enrichment analysis of a list of chemical compounds derived from a metabolomics experiment, which allows this list to be interpreted in biological terms. Since its release in 2011, MBROLE has been used by different groups worldwide to analyse metabolomics experiments from a variety of organisms. Here we present the latest version of the system, MBROLE2, accessible at http://csbg.cnb.csic.es/mbrole2 MBROLE2 has been supplemented with 10 databases not available in the previous version, which allow analysis over a larger, richer set of vocabularies including metabolite-protein and drug-protein interactions. This new version performs automatic conversion of compound identifiers from different databases, thus simplifying usage. In addition, the user interface has been redesigned to generate an interactive, more intuitive representation of the results.
© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27084944      PMCID: PMC4987872          DOI: 10.1093/nar/gkw253

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


INTRODUCTION

The final step in the analysis of high-throughput ‘omics’ experiments is typically a functional interpretation of the results, for which several bioinformatics methods have been developed. Functional enrichment, one of the most commonly used approaches for the interpretation of transcriptomics and proteomics experiments (1), can be examined with the aid of several online tools (2). These techniques analyse the functional annotations assigned to the set of genes or proteins obtained in the experiment (e.g. over- or under-expressed). Comparison of the frequency of these annotations with those of a background set allows extraction of annotations statistically enriched in the genes/protein being studied, which are used to interpret the experimental outcome in biological terms. Recent technological advances allow analysis of the small chemical compound repertories in biological samples, providing the basis of the field known as metabolomics (3). As with other ‘omics’ techniques, there is a need to interpret the results of these experiments in functional terms. The goal of functional analysis in metabolomics is to transform a long list of metabolites identified in an experiment into a reduced set of meaningful biological terms that represent, for example, the biological pathways affected (4). A few years ago, we developed MBROLE, a web-based tool for the interpretation of metabolomics experiments by functional enrichment analysis (5). Most existing tools at that time focused on the functional analysis of genes/proteins; in contrast, MBROLE and a few others focused on the analysis of chemical compounds (6–8). The first version of MBROLE contained functional (biological) data on compounds from several public databases, including the Kyoto Encyclopedia of Genes and Genomes (KEGG) (9), the Human Metabolome Database (HMDB) (10), the Chemical Entities of Biological Interest (ChEBI) database (11) and the PubChem database (pubchem.ncbi.nlm.nih.gov). MBROLE has been used to analyse metabolomics experiments carried out in organisms such as human (12), rat (13), Escherichia coli (14), Thermobifida fusca (15), Synechococcus elongates (16), Phoenix canariensis (17) or Cordyceps bassiana (18). Here, we present a new version of MBROLE whose main improvements include new metabolite functional annotations, inclusion of compound interactions with emphasis on metabolite–protein and drug–protein interactions, new supported compound identifiers, automatic conversion of identifiers, an improved user interface with a more intuitive presentation of the results and new annotation reports.

MBROLE2 ANALYSIS

MBROLE2 requires users to (i) provide a list of identifiers (IDs) corresponding to a set of chemical compounds (i.e. those found in the experiment), (ii) select the type of annotations they want to analyse and (iii) select a desired background set (e.g. an organism) (Figure 1A). Several input IDs are supported, and a ‘Conversion’ utility also accepts chemical names, CAS-Registry numbers and PubChem compounds.
Figure 1.

MBROLE2 input and output from enrichment analysis. (A) Users input a list of chemical compound IDs, select annotations to analyse and a background set. (B) Enriched annotations are shown in a table. This table (1) can be ordered by any column, (2) can show structural representations of compounds, (3) links out to external databases and (4) colours statistics to highlight significant values.

MBROLE2 input and output from enrichment analysis. (A) Users input a list of chemical compound IDs, select annotations to analyse and a background set. (B) Enriched annotations are shown in a table. This table (1) can be ordered by any column, (2) can show structural representations of compounds, (3) links out to external databases and (4) colours statistics to highlight significant values. MBROLE2 outputs an interactive table with the enriched functional annotations and their statistical significance in terms of P-value and false discovery rate (FDR). P-values are calculated with the cumulative hypergeometric distribution by comparing the number of compounds in the set and in the background with a given annotation. Resulting P-values are adjusted for multiple testing using the ‘FDR’ method (19). Users can also retrieve a table with all functional annotations for their input set of metabolites (not only those enriched); MBROLE2 can thus be used as a database of integrated metabolite annotations otherwise disseminated over several resources. In all results tables, link-outs to external resources (for both compounds and annotations) are provided to facilitate navigation and access to additional information. All results can be exported to a spreadsheet program.

Metabolite annotations

MBROLE2 allows analysis of functional annotations of chemical compounds compiled from several public databases. In addition to the databases available in the first release (KEGG, HMDB, ChEBI and PubChem), we have included data from 10 new resources comprising metabolome databases such as the Yeast Metabolome Database (YMDB) (20) and the E.coli Metabolome Database (ECMDB) (21), pathway and metabolic reaction databases such as the BioCyc Database Collection (22), Rhea (23) and UniPathway (24), and resources centred on specific classes of compounds including lipids, such as the LIPID MAPS Structure Database (LMSD) (25), and drugs, such as the Comparative Toxicogenomics Database (CTD) (26), Medical Subject Headings (MeSH) (27), the DrugBank database (28), and the Manually Annotated Targets and Drugs Online Resource (MATADOR) (29). With the addition of these databases, MBROLE2 enables analysis of a wide variety of functional annotations that describe many different aspects of the chemistry and biology of chemical compounds (see Table 1); these include pathways and sub-pathways, interactions with enzymes, proteins and other types of molecules, physiological locations, chemical classifications and taxonomies, and biological roles, uses and applications (e.g. drug indications).
Table 1.

Functional annotations that can be analysed with MBROLE2

Pathways and sub-pathwaysBioCyc, SMPDB, UniPathway, KEGG pathways, KEGG modules
InteractionsWith enzymes (ECMDB/YMDB/HMDB, KEGG, BioCyc)
With proteins (BioCyc, MATADOR, HMDB/ECMDB/YMDB)
Other molecules: bioactive peptides, lipids, etc. (KEGG)
Physiological locationCellular (HMDB/ECMDB/YMDB)
Tissue (HMDB)
Biofluid (HMDB)
Chemical classification and taxonomiesHMDB/YMDB taxonomy, KEGG classifications, LIPID MAPS taxonomy
Roles, uses and applicationsBiochemical, chemical and application (ChEBI)
Biofunctions (HMDB)
Roles (KEGG)
Drug indications (DrugBank), pharmacological actions (MeSH), Anatomical Therapeutic Chemical (ATC) classification system (for drugs)
Diseases (HMDB and CTD)

Automatic ID conversion

As input, the previous version of MBROLE required a list of chemical identifiers from the same database for which the annotations were to be analysed (e.g. a list of KEGG compounds for the analysis of KEGG pathways or a list of ChEBI accessions for analysis of ChEBI roles). Users therefore had to convert the IDs (using the MBROLE conversion utility) if they were not supported by the chosen database. In MBROLE2, we have automated the conversion of chemical IDs, such that the user provides a single ID list, which are automatically converted to those of the appropriate database, depending on the annotations chosen for analysis. This greatly simplifies input and allows users to provide a mixture of chemical IDs in the same list. Both user IDs and converted IDs are shown in the results table. To ensure unambiguous conversion, only chemical IDs are supported as input for analysis (and not metabolite names, for example). Supported input IDs in MBROLE2 include those in the first version (i.e. KEGG compounds, HMDB metabolites, PubChem compounds and ChEBI accessions) plus the new IDs: YMDB and ECMDB metabolites, LIPID MAPS lipids and METLIN metabolite database codes (30). The MBROLE2 conversion utility also accepts chemical names, CAS Registry Numbers and PubChem compound IDs. Repeated IDs are considered as a single ID in the analysis. Compound IDs with no annotations are not considered in the statistics. Input IDs with more than one correspondence in the automated conversion are considered multiple IDs in the statistics of those annotations (as many as the IDs converted).

Improved interface

Input

Through an intuitive interface, users can now choose which types of annotations to analyse. Annotations are organized into a hierarchical classification so that individual types (e.g. ‘BioCyc pathways’) or entire groups (e.g. ‘Pathways’) can be selected/deselected in the input form (Figure 1A).

Annotation search

For those users interested in retrieving a table of functional annotations (without performing enrichment analysis), we have added an ‘Annotation search’ option to MBROLE2. Those who have already performed an enrichment analysis can access the ‘Annotation search’ results directly from the enrichment output page.

Output

A single table is provided with the enriched annotations in all the vocabularies selected. Only annotations found for at least three compounds in the input set are included (Figure 1B). Users can sort the table interactively by any column. For example, to focus on annotations for a given vocabulary, the table can be sorted by the ‘Category’ column; to retrieve the most significant annotations regardless of the vocabulary they belong to, the sort can be by P-value or FDR columns, etc. To spot significant annotations conveniently, cells containing P-values and FDRs ≤ 0.001 are coloured green, yellow (for values between 0.001 and 0.05) and red (>0.05). An option is also included to export this results’ table to a spreadsheet program, so the user can perform additional calculations, post-processing and graphical representations.
  29 in total

1.  Rhynchophorus ferrugineus attack affects a group of compounds rather than rearranging Phoenix canariensis metabolic pathways.

Authors:  Antonio Giovino; Federico Martinelli; Sergio Saia
Journal:  J Integr Plant Biol       Date:  2015-12-09       Impact factor: 7.061

2.  HMDB 3.0--The Human Metabolome Database in 2013.

Authors:  David S Wishart; Timothy Jewison; An Chi Guo; Michael Wilson; Craig Knox; Yifeng Liu; Yannick Djoumbou; Rupasri Mandal; Farid Aziat; Edison Dong; Souhaila Bouatra; Igor Sinelnikov; David Arndt; Jianguo Xia; Philip Liu; Faizath Yallou; Trent Bjorndahl; Rolando Perez-Pineiro; Roman Eisner; Felicity Allen; Vanessa Neveu; Russ Greiner; Augustin Scalbert
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

3.  YMDB: the Yeast Metabolome Database.

Authors:  Timothy Jewison; Craig Knox; Vanessa Neveu; Yannick Djoumbou; An Chi Guo; Jacqueline Lee; Philip Liu; Rupasri Mandal; Ram Krishnamurthy; Igor Sinelnikov; Michael Wilson; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-11-07       Impact factor: 16.971

4.  UniPathway: a resource for the exploration and annotation of metabolic pathways.

Authors:  Anne Morgat; Eric Coissac; Elisabeth Coudert; Kristian B Axelsen; Guillaume Keller; Amos Bairoch; Alan Bridge; Lydie Bougueleret; Ioannis Xenarios; Alain Viari
Journal:  Nucleic Acids Res       Date:  2011-11-18       Impact factor: 16.971

5.  DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Savita Shrivastava; Murtaza Hassanali; Paul Stothard; Zhan Chang; Jennifer Woolsey
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

6.  LMSD: LIPID MAPS structure database.

Authors:  Manish Sud; Eoin Fahy; Dawn Cotter; Alex Brown; Edward A Dennis; Christopher K Glass; Alfred H Merrill; Robert C Murphy; Christian R H Raetz; David W Russell; Shankar Subramaniam
Journal:  Nucleic Acids Res       Date:  2006-11-10       Impact factor: 16.971

7.  Influence of the RelA Activity on E. coli Metabolism by Metabolite Profiling of Glucose-Limited Chemostat Cultures.

Authors:  Sónia Carneiro; Silas G Villas-Bôas; Eugénio C Ferreira; Isabel Rocha
Journal:  Metabolites       Date:  2012-10-12

8.  The Comparative Toxicogenomics Database's 10th year anniversary: update 2015.

Authors:  Allan Peter Davis; Cynthia J Grondin; Kelley Lennon-Hopkins; Cynthia Saraceni-Richards; Daniela Sciaky; Benjamin L King; Thomas C Wiegers; Carolyn J Mattingly
Journal:  Nucleic Acids Res       Date:  2014-10-17       Impact factor: 16.971

9.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nucleic Acids Res       Date:  2008-11-25       Impact factor: 16.971

10.  The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases.

Authors:  Ron Caspi; Richard Billington; Luciana Ferrer; Hartmut Foerster; Carol A Fulcher; Ingrid M Keseler; Anamika Kothari; Markus Krummenacker; Mario Latendresse; Lukas A Mueller; Quang Ong; Suzanne Paley; Pallavi Subhraveti; Daniel S Weaver; Peter D Karp
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

View more
  52 in total

1.  Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation.

Authors:  Paras S Minhas; Ling Liu; Peter K Moon; Amit U Joshi; Christopher Dove; Siddhita Mhatre; Kevin Contrepois; Qian Wang; Brittany A Lee; Michael Coronado; Daniel Bernstein; Michael P Snyder; Marie Migaud; Ravindra Majeti; Daria Mochly-Rosen; Joshua D Rabinowitz; Katrin I Andreasson
Journal:  Nat Immunol       Date:  2018-11-26       Impact factor: 25.606

2.  Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity.

Authors:  M J Leal-Witt; M Ramon-Krauel; S Samino; M Llobet; D Cuadras; J C Jimenez-Chillaron; O Yanes; C Lerin
Journal:  Int J Obes (Lond)       Date:  2017-08-17       Impact factor: 5.095

3.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

4.  Metabolomic profiling on rat brain of prenatal malnutrition: implicated for oxidative stress and schizophrenia.

Authors:  Fei Xu; Xin Li; Weibo Niu; Gaini Ma; Qianqian Sun; Yan Bi; Zhenming Guo; Decheng Ren; Jiaxin Hu; Fan Yuan; Ruixue Yuan; Lei Shi; Xingwang Li; Tao Yu; Fengping Yang; Lin He; Xinzhi Zhao; Guang He
Journal:  Metab Brain Dis       Date:  2019-08-13       Impact factor: 3.584

Review 5.  Untargeted Metabolomics Strategies-Challenges and Emerging Directions.

Authors:  Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-13       Impact factor: 3.109

6.  NMR-based metabolomics reveals that plant-derived smoke stimulates root growth via affecting carbohydrate and energy metabolism in maize.

Authors:  Şükrü Serter Çatav; Emine Sonay Elgin; Çağdaş Dağ; Jaime L Stark; Köksal Küçükakyüz
Journal:  Metabolomics       Date:  2018-10-15       Impact factor: 4.290

7.  Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma.

Authors:  Yongmei Li; Hao Zhuang; Xinran Zhang; Yuan Li; Yun Liu; Xianfu Yi; Guoxuan Qin; Wen Wei; Ruibing Chen
Journal:  Mol Cell Proteomics       Date:  2018-01-25       Impact factor: 5.911

Review 8.  Integrating bioinformatics approaches for a comprehensive interpretation of metabolomics datasets.

Authors:  Dinesh Kumar Barupal; Sili Fan; Oliver Fiehn
Journal:  Curr Opin Biotechnol       Date:  2018-02-06       Impact factor: 9.740

9.  Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans.

Authors:  Ryan O Walters; Esperanza Arias; Antonio Diaz; Emmanuel S Burgos; Fangxia Guan; Simoni Tiano; Kai Mao; Cara L Green; Yungping Qiu; Hardik Shah; Donghai Wang; Adam D Hudgins; Tahmineh Tabrizian; Valeria Tosti; David Shechter; Luigi Fontana; Irwin J Kurland; Nir Barzilai; Ana Maria Cuervo; Daniel E L Promislow; Derek M Huffman
Journal:  Cell Rep       Date:  2018-10-16       Impact factor: 9.423

10.  Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer.

Authors:  Olivia A Maguire; Sarah E Ackerman; Sarah K Szwed; Aarthi V Maganti; François Marchildon; Xiaojing Huang; Daniel J Kramer; Adriana Rosas-Villegas; Rebecca G Gelfer; Lauren E Turner; Victor Ceballos; Asal Hejazi; Bozena Samborska; Janane F Rahbani; Christien B Dykstra; Matthew G Annis; Ji-Dung Luo; Thomas S Carroll; Caroline S Jiang; Andrew J Dannenberg; Peter M Siegel; Sarah A Tersey; Raghavendra G Mirmira; Lawrence Kazak; Paul Cohen
Journal:  Cell Metab       Date:  2021-02-16       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.